ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,298.94
0.20%
Dow Jones
42,208.22
0.00%
Gold vs US Dollar
2,658.22
-0.01%
Brent Oil
73.475
-1.46%
Bitcoin
63,631.55
-0.99%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Purple Biotech Ltd (PPBT)

  7. Purple Biotech Ltd (PPBT) News

Purple Biotech (PPBT)

Purple Biotech Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PPBT
DateTimeSourceHeadlineSymbolCompany
18/09/202411:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
18/09/202411:30GlobeNewswire Inc.Purple Biotech Reports Additional Positive Interim Data from its Randomized Phase 2 Study with its Lead Oncology Therapeutic Candidate CM24NASDAQ:PPBTPurple Biotech Ltd
11/09/202421:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
10/09/202412:00GlobeNewswire Inc.Purple Biotech to Present Data for its Lead Oncology Drug CM24 at the AACR Special Conference on Advances in Pancreatic Cancer ResearchNASDAQ:PPBTPurple Biotech Ltd
30/08/202412:00GlobeNewswire Inc.Purple Biotech to Participate at H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:PPBTPurple Biotech Ltd
19/08/202421:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
16/08/202413:14Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
16/08/202413:12GlobeNewswire Inc.Purple Biotech Reports Second Quarter 2024 Financial Results and Business HighlightsNASDAQ:PPBTPurple Biotech Ltd
08/08/202421:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
05/08/202421:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
31/07/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PPBTPurple Biotech Ltd
25/07/202412:36Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
25/07/202412:35GlobeNewswire Inc.Purple Biotech Receives Extension to Regain Compliance with the Nasdaq’s Minimum Bid Price RuleNASDAQ:PPBTPurple Biotech Ltd
22/07/202422:00Edgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:PPBTPurple Biotech Ltd
19/07/202413:53Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
15/07/202421:15Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PPBTPurple Biotech Ltd
10/07/202412:30GlobeNewswire Inc.Purple Biotech to Host Virtual KOL Event to Discuss Positive Interim Results from Phase 2 Pancreatic Cancer Study with CM24 on July 11, 2024NASDAQ:PPBTPurple Biotech Ltd
02/07/202421:00GlobeNewswire Inc.Purple Biotech Announces Closing of Exercise of Warrants for $2 Million Gross ProceedsNASDAQ:PPBTPurple Biotech Ltd
01/07/202414:00GlobeNewswire Inc.Purple Biotech Announces Exercise of Warrants for $2 Million Gross ProceedsNASDAQ:PPBTPurple Biotech Ltd
27/06/202412:45GlobeNewswire Inc.Purple Biotech Reports Additional Positive Interim Results from its Randomized Phase 2 Pancreatic Cancer Study with CM24 Regarding a Potential Predictive Biomarker for Overall Survival BenefitNASDAQ:PPBTPurple Biotech Ltd
20/06/202414:16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
04/06/202421:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
03/06/202411:21Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
01/06/202413:00GlobeNewswire Inc.Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 Demonstrating CM24 Improved Overall Survival and other Efficacy Endpoints in Pancreatic CancerNASDAQ:PPBTPurple Biotech Ltd
21/05/202412:40Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
21/05/202412:30GlobeNewswire Inc.Purple Biotech Reports First Quarter 2024 Financial ResultsNASDAQ:PPBTPurple Biotech Ltd
25/04/202412:00GlobeNewswire Inc.Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual MeetingNASDAQ:PPBTPurple Biotech Ltd
28/03/202411:00GlobeNewswire Inc.Purple Biotech to Present New Data On its Oncology Drug NT219 at AACR 2024NASDAQ:PPBTPurple Biotech Ltd
14/03/202411:30GlobeNewswire Inc.Purple Biotech Reports Preclinical Proof of Concept for its Tribody Platform TechnologyNASDAQ:PPBTPurple Biotech Ltd
06/03/202421:06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PPBTPurple Biotech Ltd
 Showing the most relevant articles for your search:NASDAQ:PPBT

Your Recent History

LSE
PURE
Purecircle
LSE
37OR
Nat.grd.e.sw 56
BIT
UC0JN1
Unicredit Bank
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved